Literature DB >> 31166231

Incisional Injury Modulates Morphine Reward and Morphine-Primed Reinstatement: A Role of Kappa Opioid Receptor Activation.

Chinwe A Nwaneshiudu1, Xiao-You Shi2, J David Clark1,2.   

Abstract

BACKGROUND: Persistent use of prescription opioids beyond the period of surgical recovery is a large part of a public health problem linked to the current opioid crisis in the United States. However, few studies have been conducted to examine whether morphine reward is influenced by acute pain and injury.
METHODS: In a mouse model of incisional injury and minor trauma, animals underwent conditioning, extinction, and drug-primed reinstatement with morphine to examine the rewarding properties of morphine in the presence of acute incisional injury and drug-induced relapse, respectively. In addition, we sought to determine whether these behaviors were influenced by kappa opioid receptor signaling and measured expression of prodynorphin messenger RNA in the nucleus accumbens and medial prefrontal cortex after conditioning and before reinstatement with morphine and incisional injury.
RESULTS: In the presence of incisional injury, we observed enhancement of morphine reward with morphine-conditioned place preference but attenuated morphine-primed reinstatement to reward. This adaptation was not present in animals conditioned 12 days after incisional injury when nociceptive sensitization had resolved; however, they showed enhancement of morphine-primed reinstatement. Prodynorphin expression was greatly enhanced in the nucleus accumbens and medial prefrontal cortex of mice with incisional injury and morphine conditioning and remained elevated up to drug-primed reinstatement. These changes were not observed in mice conditioned 12 days after incisional injury. Further, kappa opioid receptor blockade with norbinaltorphimine before reinstatement reversed the attenuation induced by injury.
CONCLUSIONS: These findings suggest enhancement of morphine reward as a result of incisional injury but paradoxically a protective adaptation with incisional injury from drug-induced relapse resulting from kappa opioid receptor activation in the reward circuitry. Remote injury conferred no such protection and appeared to enhance reinstatement.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 31166231      PMCID: PMC7749523          DOI: 10.1213/ANE.0000000000004142

Source DB:  PubMed          Journal:  Anesth Analg        ISSN: 0003-2999            Impact factor:   5.108


  40 in total

Review 1.  Opioid therapy for chronic pain.

Authors:  Jane C Ballantyne; Jianren Mao
Journal:  N Engl J Med       Date:  2003-11-13       Impact factor: 91.245

Review 2.  Opioid-induced hyperalgesia: a qualitative systematic review.

Authors:  Martin S Angst; J David Clark
Journal:  Anesthesiology       Date:  2006-03       Impact factor: 7.892

3.  Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats.

Authors:  G Di Chiara; A Imperato
Journal:  Proc Natl Acad Sci U S A       Date:  1988-07       Impact factor: 11.205

4.  Role of substance P signaling in enhanced nociceptive sensitization and local cytokine production after incision.

Authors:  Peyman Sahbaie; Xiaoyou Shi; Tian-Zhi Guo; Yanli Qiao; David C Yeomans; Wade S Kingery; David J Clark
Journal:  Pain       Date:  2009-08-05       Impact factor: 6.961

5.  Kappa opioid receptors regulate stress-induced cocaine seeking and synaptic plasticity.

Authors:  Nicholas M Graziane; Abigail M Polter; Lisa A Briand; R Christopher Pierce; Julie A Kauer
Journal:  Neuron       Date:  2013-03-06       Impact factor: 17.173

Review 6.  The dynorphin/kappa opioid system as a modulator of stress-induced and pro-addictive behaviors.

Authors:  M R Bruchas; B B Land; C Chavkin
Journal:  Brain Res       Date:  2009-08-28       Impact factor: 3.252

7.  Involvement of dynorphin and kappa opioid receptor in yohimbine-induced reinstatement of heroin seeking in rats.

Authors:  Yan Zhou; Francesco Leri; Stephanie L Grella; Jane V Aldrich; Mary Jeanne Kreek
Journal:  Synapse       Date:  2013-02-26       Impact factor: 2.562

8.  Nor-binaltorphimine, a highly selective kappa-opioid antagonist in analgesic and receptor binding assays.

Authors:  A E Takemori; B Y Ho; J S Naeseth; P S Portoghese
Journal:  J Pharmacol Exp Ther       Date:  1988-07       Impact factor: 4.030

9.  Rates and risk factors for prolonged opioid use after major surgery: population based cohort study.

Authors:  Hance Clarke; Neilesh Soneji; Dennis T Ko; Lingsong Yun; Duminda N Wijeysundera
Journal:  BMJ       Date:  2014-02-11

10.  Inflammatory Pain Promotes Increased Opioid Self-Administration: Role of Dysregulated Ventral Tegmental Area μ Opioid Receptors.

Authors:  Lucia Hipólito; Adrianne Wilson-Poe; Yolanda Campos-Jurado; Elaine Zhong; Jose Gonzalez-Romero; Laszlo Virag; Robert Whittington; Sandra D Comer; Susan M Carlton; Brendan M Walker; Michael R Bruchas; Jose A Morón
Journal:  J Neurosci       Date:  2015-09-02       Impact factor: 6.167

View more
  3 in total

Review 1.  Factors mediating pain-related risk for opioid use disorder.

Authors:  Arbi Nazarian; S Stevens Negus; Thomas J Martin
Journal:  Neuropharmacology       Date:  2021-01-30       Impact factor: 5.250

2.  Kappa Opioid Signaling at the Crossroads of Chronic Pain and Opioid Addiction.

Authors:  Catherine M Cahill; Lindsay Lueptow; Hannah Kim; Raj Shusharla; Amy Bishop; Christopher J Evans
Journal:  Handb Exp Pharmacol       Date:  2022

3.  The bivalent ligand, MMG22, reduces neuropathic pain after nerve injury without the side effects of traditional opioids.

Authors:  Rebecca Speltz; Mary M Lunzer; Sarah S Shueb; Eyup Akgün; Rachelle Reed; Alex Kalyuzhny; Philip S Portoghese; Donald A Simone
Journal:  Pain       Date:  2020-09-01       Impact factor: 7.926

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.